TMCnet News
Orthofix International Announces Conference Call to Discuss Full-Year 2013 Results and Filing of RestatementLEWISVILLE, Texas --(Business Wire)-- Orthofix International N.V. (NASDAQ:OFIX) will hold a conference call and webcast on Thursday, March 27, 2014 at 8:30 a.m. ET to discuss its financial results for the year ended December 31, 2013, which it expects to release at approximately 6:00 a.m. ET that same day. Additionally, the Company will discuss its restated financial statements for certain prior periods, which the Company is filing today with the Securities and Exchange Commission. Interested parties may access the conference call by dialing (888) 267-2845 in the U.S. and (973) 413-6102 outside the U.S., and entering the conference ID 38220. A replay of the call will be available for two weeks by dialing (800) 332-6854 in the U.S. and (973) 528-0005 outside the U.S., and entering the conference ID 38220. A webcast of the onference call may be accessed by going to the company's website at www.orthofix.com, by clicking on the Investors link and then the Events and Presentations page. About Orthofix Orthofix International N.V. is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the company's sales representatives, stocking distributors and its subsidiaries. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation and the Texas Scottish Rite Hospital for Children. For more information, please visit www.orthofix.com.
|
